| | | | | | | |
 | JOHNSON & JOHNSON | 0.13% | -0.79% | -7.38% | -4.61% | 7.72% | 427 756 |
| ELI LILLY AND COMPANY | 0.31% | -1.30% | -6.86% | 42.02% | 132.72% | 323 754 |
 | NOVO NORDISK A/S | -0.29% | 3.01% | 3.20% | 40.70% | 123.74% | 315 573 |
| MERCK & CO., INC. | 0.91% | -0.32% | -3.88% | 38.66% | 25.34% | 270 375 |
| ABBVIE INC. | -0.37% | -1.36% | -10.52% | 0.77% | 56.69% | 255 653 |
 | ROCHE HOLDING AG | -0.58% | 2.63% | -1.86% | -19.89% | -16.09% | 253 767 |
| PFIZER, INC. | 0.89% | -1.29% | -14.17% | -14.93% | 15.58% | 246 874 |
 | ASTRAZENECA PLC | 4.97% | 4.59% | 0.61% | 34.93% | 46.38% | 201 106 |
| NOVARTIS AG | 0.85% | 0.12% | -3.10% | 0.51% | -14.35% | 184 836 |
| BRISTOL-MYERS SQUIBB COMPANY | -1.17% | 2.57% | 2.36% | 11.78% | 11.17% | 163 477 |
| AMGEN INC. | -1.56% | -2.52% | -8.54% | -0.34% | 4.74% | 128 166 |
 | SANOFI | 0.86% | -0.21% | -0.63% | -4.49% | -4.49% | 118 451 |
| GILEAD SCIENCES, INC. | -0.44% | 1.99% | -0.21% | 34.49% | 24.39% | 106 830 |
| GSK PLC | 0.87% | 5.73% | 5.31% | -25.27% | -29.48% | 73 095 |
 | BAYER AG | -0.05% | 10.60% | 29.25% | 17.19% | -19.01% | 65 864 |
| | | | | | | |
| | Gemiddelde | 0.36% | 1.56% | -1.10% | 10.10% | 24.34% | |
| | Gewogen gemiddelde per kap. | 0.37% | 0.78% | -3.52% | 12.06% | 36.42% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
